Physician profile
Jeffrey Watson
NPI 1053629527
$703.86
in general payments reported to CMS, 2019-2025
13 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.37 · 2020: $61.00 · 2021: $38.26 · 2022: $51.50 · 2023: $256 · 2024: $108 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $194.52 | 2023 | |
| Stryker Corporation | $104.25 | 2020-2025 | Focess |
| Intersect Ent, INC. | $55.77 | 2019-2021 | |
| Merz North America, INC. | $44.23 | 2025 | |
| Genzyme Corporation | $43.89 | 2023 | |
| Inspire Medical Systems, INC. | $43.75 | 2024-2025 | Inspire |
| Integra Lifesciences Corporation | $43.52 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Cochlear Americas | $40.29 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Abbvie INC. | $35.53 | 2023-2024 | |
| Olympus America INC. | $29.69 | 2019 | |
| Baudax Bio INC. | $23.56 | 2020 | |
| Galderma Laboratories, L.P. | $23.17 | 2021 | |
| Optinose US, INC. | $21.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.